3Gladman J .Pharmacisis paid to improve drug compliance, persistency[J] .Payment Strategies Pharm Care, 1997,10 : 4.
4黄葆钧,严棠译.治疗学争论[M].北京:人民卫生出版社,1987:434-439.
5Wetzels GE, Nelemans P, Schouten JS, et al. Facts and fiction of poor pliant as a cause of inadequate blood pressure control A systematic review[J]. Hypertension, 2004,22(8) :1 849.
6McDonald FP,Garg AX, Haynes RB. Interventions to enhance patient adherence to me dication prescriptions [J]. JAMA, 2002,288(22) : 2 868.
7Mueller S O. Gentoxicity of the laxative drug components emodin,aloe-emodin and danthron in mammalian ceils: eopoisomerase Ⅱ mediated [ J ]. Mutat Res , 1996,371 : 165
9ManciaC, BackerG, CilkovaR, et al.2007 Guidelines for the Management of Arterial Hypertension:The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension( ESH )and of the European Society of Cardiology( ESC ) [J] .Eur Heart J, 2007, 28 ( 12 ) : 1462-536.
10RybackiJ J. Improving cardiovascular health in postmenopausal women by addressing medication adherence issues [ J ] .J Am PharmAssoc, 2002, 42 ( 1 ) : 63.
